-
Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil
Friday, December 6, 2024 - 3:45pm | 834Canada’s dried flower exports have seen impressive growth, doubling year-over-year in 3Q24, with the sector hitting record levels in October. According to Pablo Zuanic, senior analyst at Zuanic & Associates, “The strong growth in dried flower exports signals a thriving international...
-
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
Thursday, December 5, 2024 - 12:05pm | 1114We’ve been analyzing cannabis stocks from a mid-term investor perspective, covering major players like Aurora (NASDAQ:ACB):, Canopy (NASDAQ:CGC):, and High Tide (NASDAQ:HITI), all listed on major exchanges. Now, we’ll shift focus to the first case of a cannabis stock traded OTC, which...
-
Curaleaf Q3 Results: Strong Margins But $44M Loss, What's Next For Investors?
Wednesday, November 6, 2024 - 6:41pm | 413The company reported a net loss of $44 million, equivalent to $0.07 per share, with adjusted EBITDA at $75.3 million. Curaleaf Holdings, Inc. (OTC:CURLF) posted its third-quarter revenue of $331 million on Wednesday afternoon, marking a modest 1% year-over-year decline. Gross profit reached $160.5...
-
The Future Of Cannabis: 'A Tremendous Amount Of Upside' Despite Challenges Says Curaleaf Executive
Wednesday, October 16, 2024 - 9:15am | 643As the cannabis industry eagerly watches for changes to federal regulations, Boris Jordan, executive chairman of Curaleaf, weighed in on how potential rescheduling could reshape both the U.S. and international cannabis markets. During his interview at the Benzinga Cannabis Capital Conference,...
-
2 Million Brits Are Self Medicating With Cannabis, The Market Soars 10% Monthly - Will National Health Service Prescriptions Catch Up?
Thursday, August 29, 2024 - 10:05pm | 705The UK’s medical cannabis market is expanding rapidly, with growth estimated at around 10% per month, according to Jon Robson, CEO of Mamedica, a leading medical cannabis clinic. Despite this impressive growth, access to medical cannabis remains largely confined to illicit channels and...
-
Strategy Shift In The Works? Are Cannabis Giants Getting Into The Hemp Derived-THC Market?
Wednesday, July 17, 2024 - 12:13pm | 656America's largest cannabis companies are reconsidering their stance on hemp-derived products. Historically, they pushed for them to remain illegal. However, some companies, such as Curaleaf (OTC:CURLF), have recently changed strategy. Curaleaf’s New Direction A key player in the industry,...
-
Curaleaf's 'Rooted In Good' Drives Diversity In The Cannabis Industry
Wednesday, May 22, 2024 - 11:32am | 642Curaleaf (OTC:CURLF), a major player in the cannabis industry, is advancing diversity through its philanthropic arm, Rooted In Good. This initiative is focused on empowering minority-owned businesses by offering crucial funding and exposure opportunities. The 2024 Canna Founders Pitch Competition,...
-
Curaleaf's Dual Expansion: Balancing Medical And Recreational Markets While Emphasizing Social Equity (CORRECTED)
Monday, May 13, 2024 - 3:20pm | 615Editor’s note: This story has been corrected to reflect that Curaleaf is headquartered in New York City. Curaleaf CEO Matt Darin told Benzinga at the Cannabis Capital Conference in Miami that the company has recently increased its presence in New York. The New York City-based...
-
Curaleaf Reports Q1 2024 Revenue Of $339M, 48% Gross Margin Amid Strategic Global Expansion
Thursday, May 9, 2024 - 7:52pm | 447Curaleaf Holdings, Inc. (OTC: CURLF), a leading international cannabis company, reported its financial results for the first quarter of 2024. Curaleaf’s CEO, Matt Darin, highlighted the company's focus on expanding its brand globally, leveraging significant market catalysts such as...
-
New Tax Rules In Cannabis: What Are The Consequences DEA Rescheduling?
Thursday, May 2, 2024 - 4:09pm | 797In a significant shift for the cannabis industry, marijuana is set to be reclassified as a Schedule 3 controlled substance. While this change does not address the ongoing federal prohibition, removal of the 280E IRS tax code will have substantial consequences for the cannabis space, particularly...
-
How Will Germany's Cannabis Legalization Change The Game?
Tuesday, March 19, 2024 - 4:35pm | 897Germany recently made headlines by legalizing recreational cannabis in February, joining Malta and Luxembourg as pioneers in the EU. The German parliament’s approval of the CanG bill marks a major shift in the nation’s drug policy, moving away from strict prohibitions. This legislation...
-
US At Cannabis Crossroads: VP Harris Urges DEA Action, Where Do Industry Leaders Stand?
Tuesday, March 19, 2024 - 11:46am | 999In a bold stance on U.S. cannabis policy, Vice President Kamala Harris is urging the Drug Enforcement Administration (DEA) to accelerate the process of rescheduling marijuana under the Controlled Substances Act. Speaking at a recent White House meeting with individuals who received pardons for...
-
EXCLUSIVE: Curaleaf's Boris Jordan Puts Premium On Cannabis Quality, Says 'We Want To Be The Best'
Thursday, October 5, 2023 - 12:24pm | 473Curaleaf Holdings Inc (OTC:CURLF) founder and executive chair Boris Jordan opened up on the company’s commitment to enhancing flower quality during an exclusive interview at Benzinga’s Cannabis Capital Conference (CCC). “Curaleaf has always been an innovator on the product side,...
-
Exploring Latest Cannabis Products: THC Gummies, Drops, THCA Diamonds & More, A Conference Elevating Cannabis Brands
Monday, August 14, 2023 - 10:19am | 1088Hello, fellow cannabis enthusiasts! Get ready to be dazzled by a thrilling weekly lineup of the hottest cannabis product launches, brought to you by Benzinga. With notable industry figures like Randa McMinn, CMO of WM Technology, Inc. (NASDAQ: MAPS) known as Weedmaps, Patrick Lane, EVP of...
-
XS Financial Touts 140% YoY Increase In Revenue Despite Cannabis Industry Slowdown
Tuesday, April 25, 2023 - 5:53pm | 553XS Financial Inc. (CSE: XSF) (OTCQB: XSHLF) released earnings for the fourth quarter and fiscal year ended December 31, 2022. The specialty finance company, which is dedicated to U.S.-based cannabis companies, had "a transformational year," according to CEO David Kivitz. "We had...